Home/Filings/4/A/0001618835-20-000203
4/A//SEC Filing

Hall William Walmsley 4/A

Accession 0001618835-20-000203

CIK 0001618835other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:29 PM ET

Size

5.4 KB

Accession

0001618835-20-000203

Insider Transaction Report

Form 4/AAmended
Period: 2020-06-15
Transactions
  • Purchase

    Common Stock

    2020-06-15$2.85/sh+5,000$14,2505,000 total
Footnotes (2)
  • [F1]The original Form 4, filed on June 17,2020, is being amended to update the price range reported in Column 4 of Table I.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.845 to $2.85, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1
  • filerCIK 0001726731

Filing Metadata

Form type
4/A
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:29 PM ET
Size
5.4 KB